Pediatric food allergy and mucosal tolerance

Mucosal Immunology

Volumn 3, Issue 4, 2010, Pages 345-354

  Scurlock, A M ^a   Vickery, B P ^b   Hourihane, Jo O ^c   Burks, A W ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CHINESE DRUG; DIPHENHYDRAMINE; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT PROTEIN; SALBUTAMOL;

DRUG MECHANISM; FOOD ALLERGY; GASTROINTESTINAL MUCOSA; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; REVIEW; SENSITIZATION;

EID: 77953752176     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2010.21     Document Type: Review

References (89)

1. Altschul, A. S., Scherrer, D. L., Munoz-Furlong, A. & Sicherer, S. H. Manufacturing and labeling issues for commercial products: relevance to food allergy. J. Allergy Clin. Immunol. 108, 468 (2001).
2. Joshi, P., Mofi di, S. & Sicherer, S. H. Interpretation of commercial food ingredient labels by parents of food-allergic children. J. Allergy Clin. Immunol. 109, 1019-1021 (2002).
3. Sicherer, S. H., Burks, A. W. & Sampson, H. A. Clinical features of acute allergic reactions to peanut and tree nuts in children. Pediatrics 102, e6 (1998).
4. Bock, S. A., Munoz-Furlong, A. & Sampson, H. A. Further fatalities caused by anaphylactic reactions to food, 2001 - 2006. J. Allergy Clin. Immunol. 119, 1016 - 1018 (2007).
5. Clark, S. et al. Multicenter study of emergency department visits for food allergies. J. Allergy Clin. Immunol. 113, 347-352 (2004). (Pubitemid 38210561)
6. Bollinger, M. E. et al. The impact of food allergy on the daily activities of children and their families. Ann. Allergy Asthma Immunol. 96, 415-421 (2006).
7. DunnGalvin, A., de BlokFlokstra, B. M. J., Burks, A. W., Dubois, E. J. & Hourihane, J. O ' B. Food allergy QoL questionnaire for children aged 0 - 12 years: content, construct, and cross-cultural validity. Clin. Exp. Allergy 38, 977-988 (2008).
8. King, R. M., Knibb, R. C. & Hourihane, J. O ' B. Impact of peanut allergy on quality of life, stress and anxiety in the family. Allergy 64, 461-468 (2009).
9. Cohen, B. L., Noone, S., Munoz-Furlong, A. & Sicherer, S. H. Development of a questionnaire to measure quality of life in families with a child with food allergy. J. Allergy Clin. Immunol. 114, 1159-1163 (2004).
10. Sicherer, S. H., Noone, S. A. & Munoz-Furlong, A. The impact of childhood food allergy on quality of life. Ann. Allergy Asthma Immunol. 87, 461-464 (2001).
11. Beyer, K. et al. Human milk-specifi c mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profi le. J. Allergy Clin. Immunol. 109, 707-713 (2002).
12. Curotto de Lafaille, M. A. et al. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic infl ammation. Immunity 29, 114-126 (2008).
13. Karlsson, M. R., Rugtveit, J. & Brandtzaeg, P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J. Exp. Med. 199, 1679-1688 (2004).
14. Shreffl er, W. G., Wanich, N., Moloney, M., Nowak-Wegrzyn, A. & Sampson, H. A. Association of allergen-specifi c regulatory T cells with the onset of clinical tolerance to milk protein. J. Allergy Clin. Immunol. 123, 43-52 (2009).
15. da Silva Menezes, J. et al. Stimulation by food proteins plays a critical role in the maturation of the immune system. Int. Immunol. 15, 447-455 (2003).
16. Chase, M. W. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Soc. Exp. Biol. 61, 257-259 (1946).
17. Chehade, M. & Mayer, L. Oral tolerance and its relation to food hypersensitivities. J. Allergy Clin. Immunol. 115, 3-12 (2005).
18. Friedman, A. & Weiner, H. L. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 91, 6688-6692 (1994).
19. Strobel, S. & Mowat, A. M. Oral tolerance and allergic responses to food proteins. Curr. Opin. Allergy Clin. Immunol. 6, 207-213 (2006).
20. Worbs, T. et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J. Exp. Med. 203, 519-527 (2006).
21. Coombes, J. L. et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-\{beta\} and retinoic acid dependent mechanism. J. Exp. Med. 204, 1757-1764 (2007).
22. Lack, G. Epidemiologic risks for food allergy. J. Allergy Clin. Immunol. 121, 1331-1336 (2008).
23. Jones, S. M. et al. Clinical effi cacy and immune regulation with peanut oral immunotherapy. J. Allergy Clin. Immunol. 124, 292-300 (2009).
24. Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T-cells. Nat. Immunol. 4, 330-336 (2003).
25. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. (Reports). Science 299, 1057 (2003).
26. Bennett, C. L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21 (2001).
27. Torgerson, T. R. et al. Severe food allergy as a variant of IPEX Syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology 132, 1705-1717 (2007).
28. Ganeshan, K. et al. Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model. J. Allergy Clin. Immunol. 123, 231-238 (2009).
29. Blazquez, A. B. & Berin, M. C. Gastrointestinal dendritic cells promote Th2 skewing via OX40L. J. Immunol. 180, 4441-4450 (2008).
30. Mayer, L. Mucosal immunity. Pediatrics 111, 1595-1600 (2003).
31. Michael, J. G. The role of digestive enzymes in orally induced immune tolerance. Immunol. Invest. 18, 1049-1054 (1989).
32. Barone, K. S., Reilly, M. R., Flanagan, M. P. & Michael, J. G. Abrogation of oral tolerance by feeding encapsulated antigen. Cell. Immunol. 199, 65-72 (2000).
33. Scott, H., Solheim, B. G., Brandtzaeg, P. & Thorsby, E. HLA-DR-like antigens in the epithelium of the human small intestine. Scand J. Immunol. 12, 77-82 (1980).
34. Groschwitz, K. R. & Hogan, S. P. Intestinal barrier function: molecular regulation and disease pathogenesis. J. Allergy Clin. Immunol. 124, 3-20 (2009).
35. Ventura, M. T. et al. Intestinal permeability in patients with adverse reactions to food. Dig. Liver Dis. 38, 732-736.
36. Laudat, A., Arnaud, P., Napoly, A. & Brion, F. The intestinal permeability test applied to the diagnosis of food allergy in paediatrics. West Indian Med. J. 43, 87-88 (1994).
37. Lacaille, F., Laurent, J. & Bousquet, J. Life-threatening food allergy in a child treated with FK506. [Report]. J. Pediatr. Gastroenterol. Nutr. 25, 228-229 (1997).
38. Granot, E., Yakobovich, E. & Bardenstein, R. Tacrolimus immunosuppression - an association with asymptomatic eosinophilia and elevated total and specifi c IgE levels. Pediatr. Transplant. 10, 690-693 (2006).
39. Gabe, S. M. et al. The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. Gastroenterology 115, 67-74 (1998).
40. Boyle, R. J. & Hardikar, W. T. M. The development of food allergy after liver transplantation. Liver Transpl. 11, 326-330 (2005).
41. Chehade, M. et al. De Novo food allergy after intestinal transplantation: a report of three cases. [Report]. J. Pediatr. Gastroenterol. Nutr. 38, 545-547 (2004).
42. Madsen, K. L., Yanchar, N. L., Sigalet, D. L., Reigel, T. & Fedorak, R. N. FK506 increases permeability in rat intestine by inhibiting mitochondrial function. Gastroenterology 109, 107-114 (1995).
43. Forbes, E. E. et al. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J. Exp. Med. 205, 897-913 (2008).
44. Till, S. J., Francis, J. N., Nouri-Aria, K. & Durham, S. R. Mechanisms of immunotherapy. J. Allergy Clin. Immunol. 113, 1025-1034 (2004).
45. Francis, J. N. et al. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J. Allergy Clin. Immunol. 121, 1120-1125 (2008).
46. Oppenheimer, J. J., Nelson, H. S., Bock, S. A., Christensen, F. & Leung, D. Y. Treatment of peanut allergy with rush immunotherapy 90, 256-262 (1992).
47. Nelson, H. S., Lahr, J., Rule, R., Bock, S. A. & Leung, D. Y. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J. Allergy Clin. Immunol. 99, 744-751 (1997).
48. Li, X. M. et al. Persistent protective effect of heat-killed Escherichia coli producing " engineered, " recombinant peanut proteins in a murine model of peanut allergy. J. Allergy Clin. Immunol. 112, 159-167 (2003).
49. Li, X. M. et al. Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J. Immunol. 170, 3289-3295 (2003).
50. Yang, M., Yang, C. & Mine, Y. Multiple T cell epitope peptides suppress allergic responses in an egg allergy mouse model by the elicitation of forkhead box transcription factor 3- and transforming growth factor- β - associated mechanisms. Clin. Exp. Allergy 40, 668 - 678 (2010).
51. Srivastava, K. D. et al. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J. Allergy Clin. Immunol. 115, 171-178 (2005).
52. Qu, C. et al. Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula-2 is associated with upregulation of interferon-gamma. Clin. Exp. Allergy 37, 846-855 (2007).
53. Srivastava, K. D. et al. Food allergy herbal formula-2 silences peanutinduced anaphylaxis for a prolonged posttreatment period via IFN- [gamma]-producing CD8+ T cells. J. Allergy Clin. Immunol. 123, 443-451 (2009).
54. Senti, G. et al. Epicutaneous allergen administration as a novel method of allergen-specifi c immunotherapy. J. Allergy Clin. Immunol. 124, 997-1002 (2009).
55. Mondoulet, L. et al. Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy. Clin. Exp. Allergy 40, 659 - 667 (2010).
56. Enrique, E. et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J. Allergy Clin. Immunol. 116, 1073-1079 (2005).
57. Mempel, M., Rakoski, J., Ring, J. & Ollert, M. Severe anaphylaxis to kiwi fruit: immunologic changes related to successful sublingual allergen immunotherapy. J. Allergy Clin. Immunol. 111, 1406-1409 (2003).
58. Kerzl, R., Simonowa, A., Ring, J., Ollert, M. & Mempel, M. Life-threatening anaphylaxis to kiwi fruit: Protective sublingual allergen immunotherapy effect persists even after discontinuation. J. Allergy Clin. Immunol. 119, 507-508 (2007).
59. Patriarca, G. et al. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment. Pharmacol. Ther. 17, 459-465 (2003).
60. Meglio, P., Bartone, E., Plantamura, M., Arabito, E. & Giampietro, P. G. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 59, 980-987 (2004).
61. Buchanan, A. D. et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J. Allergy Clin. Immunol. 119, 199-205 (2007).
62. Lemon-Mule, H. et al. Immunologic changes in children with egg allergy ingesting extensively heated egg. J. Allergy Clin. Immunol. 122, 977-983 (2008).
63. Staden, U. et al. Specifi c oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 62, 1261-1269 (2007).
64. Longo, G. et al. Specifi c oral tolerance induction in children with very severe cow's milk-induced reactions. J. Allergy Clin. Immunol. 121, 343-347 (2008).
65. Staden, U. et al. Rush oral immunotherapy in children with persistent cow's milk allergy. J. Allergy Clin. Immunol. 122, 418-419 (2008).
66. Skripak, J. M. et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J. Allergy Clin. Immunol. 122, 1154-1160 (2008).
67. Narisety, S. D. et al. Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy. J. Allergy Clin. Immunol. 124, 610-612 (2009).
68. Clark, A. T. et al. Successful oral tolerance induction in severe peanut allergy. Allergy 64, 1218-1220 (2009).
69. Hofmann, A. M. et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J. Allergy Clin. Immunol. 124, 286-291 (2009).
70. Varshney, P. et al. Adverse reactions during peanut oral immunotherapy home dosing. J. Allergy Clin. Immunol. 124, 1351-1352 (2009).
71. DunnGalvin, A. et al. Profi ling families enrolled in food allergy immunotherapy studies. Pediatrics 124, e503-e509 (2009).
72. Grundy, J., Matthews, S., Bateman, B., Dean, T. & Arshad, S. H. Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts. J. Allergy Clin. Immunol. 110, 784-789 (2002).
73. Hourihane, J. O. et al. The impact of government advice to pregnant mothers regarding peanut avoidance on the prevalence of peanut allergy in United Kingdom children at school entry. J. Allergy Clin. Immunol. 119, 1197-1202 (2007).
74. Sicherer, S. H., Mu ñ oz-Furlong, A. & Sampson, H. A. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J. Allergy Clin. Immunol. 112, 1203-1207 (2003).
75. Committee on Toxicity. COT report on peanut allergy, http://cot.food.gov. uk/cotreports/cotwgreports/cotpeanutallergy (1998).
76. American Academy of Pediatrics Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics 106, 346-349 (2000).
77. Levy, Y., Broides, A., Segal, N. & Danon, Y. L. Peanut and tree nut allergy in children: role of peanut snacks in Israel? Allergy 58, 1206-1207 (2003).
78. Du Toit, G. et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J. Allergy Clin. Immunol. 122, 984-991 (2008).
79. Fox, A. T., Sasieni, P., Du Toit, G., Syed, H. & Lack, G. Household peanut consumption as a risk factor for the development of peanut allergy. J. Allergy Clin. Immunol. 123, 417-423 (2009).
80. Strid, J., Hourihane, J. O ' B., Kimber, I., Callard, R. & Strobel, S. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur. J. Immunol. 34, 2100-2109 (2004).
81. Hsieh, K. Y., Tsai, C. C., Wu, C. H. & Lin, R. H. Epicutaneous exposure to protein antigen and food allergy. Clin. Exp. Allergy 33, 1067-1075 (2003).
82. Strid, J., Hourihane, J. O ' B., Kimber, I., Callard, R. & Strobel, S. Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clin. Exp. Allergy 35, 757-766 (2005).
83. O ' Regan, G. M., Sandilands, A., McLean, W. H. I. & Irvine, A. D. Filaggrin in atopic dermatitis. J. Allergy Clin. Immunol. 122, 689-693 (2008).
84. Fallon, P. G. et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat. Genet. 41, 602-608 (2009).
85. de Benedictis, F. M., et al. & EPAAC Study Group The allergic sensitization in infants with atopic eczema from different countries. Allergy 64, 295-303 (2009).
86. Filipiak, B. et al. Solid food introduction in relation to eczema: results from a four-year prospective birth cohort study. J. Pediatr. 151, 352-358 (2007).
87. Zutavern, A. et al. Timing of solid food introduction in relation to eczema, asthma, allergic rhinitis, and food and inhalant sensitization at the age of 6 years: results from the prospective birth cohort study LISA. Pediatrics 121, e44-e52 (2008).
88. Greer, F. R., Sicherer, S. H., Burks, A. W. & the Committee on Nutrition and Section on Allergy and Immunology Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 121, 183-191 (2008).
89. Agostoni, C., et al. & ESPGHAN committee on nutrition Complementary feeding: a commentary by the ESPGHAN committee on nutrition. J. Pediatr. Gastroenterol. Nutr. 46, 99-110 (2008).